Zobrazeno 1 - 10
of 11
pro vyhledávání: '"C. J. Greenbaum"'
Autor:
C. J. Greenbaum
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 85:1255-1260
Autor:
C. J. Greenbaum
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 74:1040-1044
Publikováno v:
Greenbaum, CJ; Havel, PJ; Taborsky, GJ; & Klaff, LJ. (1991). Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.. The Journal of clinical investigation, 88(3), 767-773. doi: 10.1172/jci115375. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/2sg4377x
The Journal of clinical investigation, vol 88, iss 3
The Journal of clinical investigation, vol 88, iss 3
Inhibition of pancreatic glucagon secretion during hyperglycemia could be mediated by (a) glucose, (b) insulin, (c) somatostatin, or (d) glucose in conjunction with insulin. To determine the role of these factors in the mediation of glucagon suppress
Autor:
C. J. Greenbaum, Jerry P. Palmer
Publikováno v:
Diabetic Medicine. 8:97-105
Antibodies to insulin are of two types, insulin antibodies which occur in patients who have been exposed to exogenous insulin treatment, and insulin autoantibodies which appear in insulin-naive subjects. The occurrence and clinical significance of th
Autor:
D. K. McCulloch, L. J. Klaff, S. E. Kahn, S. L. Schoenfeld, C. J. Greenbaum, R. S. Mauseth, E. A. Benson, G. T. Nepom, L. Shewey, J. P. Palmer
Publikováno v:
Diabetes. 39:549-556
Autor:
D G, Alleva, R A, Maki, A L, Putnam, J M, Robinson, M S, Kipnes, P, Dandona, J B, Marks, D L, Simmons, C J, Greenbaum, R G, Jimenez, P J, Conlon, P A, Gottlieb
Publikováno v:
Scandinavian journal of immunology. 63(1)
NBI-6024 is an altered peptide ligand (APL) corresponding to the 9-23 amino acid region of the insulin B chain (B(9-23)), an epitope recognized by inflammatory interferon-gamma-producing T helper (Th)1 lymphocytes in type 1 diabetic patients. Immunom
Publikováno v:
Scandinavian journal of immunology. 56(5)
Levels of nonantigen-induced pro-inflammatory cytokines and prostaglandin in macrophages isolated from human leucocyte antigen (HLA)-matched type 1 diabetes mellitus patients, first-degree relatives and healthy controls were determined. We hypothesiz
Publikováno v:
Diabetes. 50(2)
The clinical presentation of type 1 diabetes usually involves symptoms such as polyuria and polydipsia. However, investigators in the Diabetes Prevention Trial of Type 1 Diabetes (DPT-1) have detected a group of subjects with type 1 diabetes who have
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(3)
The presence of human leukocyte antigen (HLA) haplotype DQA1*0102, DQB1*0602 is associated with protection from type 1 diabetes. The Diabetes Prevention Trial-type 1 has identified 100 islet cell antibody (ICA)-positive relatives with this protective
Publikováno v:
Journal of periodontology. 67(8)
This investigation studied relative changes in periodontal conditions of 18 insulin-dependent diabetic patients. Measures of gingival inflammation, crevicular fluid aspartate aminotransferase (AST) levels, probing depth and attachment levels, the pre